Dietary modification of myeloid-derived suppressor cells (MDSC) activity in sepsis
- PMID: 35290112
- PMCID: PMC8944247
- DOI: 10.1073/pnas.2201396119
Dietary modification of myeloid-derived suppressor cells (MDSC) activity in sepsis
Conflict of interest statement
Competing interest statement: J.B.O.G. was the Chief Medical Officer for North America for Nestle Health Science until July 1, 2018 and does not have any current legal, contractual, or economic ties with this company or any interest in any other company. He was the Medical Director for the Surgical Intensive Care Unit at Ochsner Medical Center until November 2019. Ochsner Health and Louisiana State University jointly submitted a patent on arginine deficiency, arginase, and MDSC in COVID-19 but J.B.O.G. does not know the status of this patent.
Figures
![Fig. 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3278/8944247/3cf949c88518/pnas.2201396119fig01.gif)
Comment on
-
Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction.Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):e2115139119. doi: 10.1073/pnas.2115139119. Proc Natl Acad Sci U S A. 2022. PMID: 35173051 Free PMC article.
Similar articles
-
S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.Mol Immunol. 2019 Aug;112:72-81. doi: 10.1016/j.molimm.2019.04.019. Epub 2019 May 9. Mol Immunol. 2019. PMID: 31078118 Free PMC article.
-
HIF-1α-Deficiency in Myeloid Cells Leads to a Disturbed Accumulation of Myeloid Derived Suppressor Cells (MDSC) During Pregnancy and to an Increased Abortion Rate in Mice.Front Immunol. 2019 Feb 5;10:161. doi: 10.3389/fimmu.2019.00161. eCollection 2019. Front Immunol. 2019. PMID: 30804946 Free PMC article.
-
Myeloid-derived Suppressor Cells in Sepsis.Am J Respir Crit Care Med. 2017 Aug 1;196(3):256-258. doi: 10.1164/rccm.201701-0046ED. Am J Respir Crit Care Med. 2017. PMID: 28762789 No abstract available.
-
Role of myeloid derived suppressor cells in sepsis.Int Immunopharmacol. 2022 Mar;104:108452. doi: 10.1016/j.intimp.2021.108452. Epub 2022 Jan 4. Int Immunopharmacol. 2022. PMID: 34996010 Review.
-
Myeloid cells in sepsis-acquired immunodeficiency.Ann N Y Acad Sci. 2021 Sep;1499(1):3-17. doi: 10.1111/nyas.14333. Epub 2020 Mar 23. Ann N Y Acad Sci. 2021. PMID: 32202669 Review.
Cited by
-
The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice.Heliyon. 2024 Feb 5;10(3):e25595. doi: 10.1016/j.heliyon.2024.e25595. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38356581 Free PMC article.
-
Immunomodulatory actions of myeloid-derived suppressor cells in the context of innate immunity.Innate Immun. 2024 Jan;30(1):2-10. doi: 10.1177/17534259231215581. Epub 2023 Nov 28. Innate Immun. 2024. PMID: 38018014 Free PMC article. Review.
References
-
- Angus D. C., van der Poll T., Severe sepsis and septic shock. N. Engl. J. Med. 369, 840–851 (2013). - PubMed
-
- Mizoguchi H., et al. , Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258, 1795–1798 (1992). - PubMed
-
- Zhu X., et al. , The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury. Ann. Surg. 259, 171–178 (2014). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical